Publications

Latest

16 Jun 2021

Activity Report 2020

GARDP continued to make progress in 2020 despite the challenges of the COVID-19 pandemic. The Activity Report 2020 showcases the work of GARDP to develop treatments for the drug-resistant infections posing the greatest threat to health, and to ensure these treatments are responsibly available for all who need them. Available in English | Deutsch | Français.

All

Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug‑Resistant Bacteria

Towards the sustainable discovery and development of new antibiotics

Pharmacodynamic Evaluation of Dosing, Bacterial Kill, and Resistance Suppression for Zoliflodacin Against Neisseria gonorrhoeae in a Dynamic Hollow Fiber Infection Model

Financial Report 2020

Activity Report 2020: Executive Summary

Systematic review and meta-analysis of in vitro eﬃcacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli

Cookie Policy

We use cookies to provide you a better experience and understand how our site is being used. To consent to the use of cookies, click ‘Accept’. Learn more about our cookie and privacy policy.